X
  • Number
  • FLOSEP-A-003D

Introduction

This product uses SANY Hematopoietic patent "bisspecific antibody preparation technology" to simultaneously pair red blood cells and target cells in whole blood, and then uses traditional Ficoll density gradient centrifugation to directly separate/remove target cells from whole blood, which can be used for untouchable cell sorting conveniently and quickly. The amount of blood treated was 50ml whole blood. This product can be used to remove more than 90% of CD3+ cells, providing a powerful tool for basic and clinical research.

Advantage

Easy to operate, no magnetic pole required
The operation is fast and the target cells can be separated/removed in the density gradient centrifugation process
The removal rate of target cells is high, and more than 90% of target cells can be removed
It can be used for untouchable cell sorting to maintain the original cell ecology and have little impact on subsequent experiments

Details Document

Related products

Related Products